Table 1.

Patient Data.

	Survivors	Non-Survivors	NLT	Controls
Age (years)	38 ± 3	40 ± 6	34 ± 5	34 ± 3
% Female	85	88	80	75
Peak ALT (U/L)	3943 ± 605	5729 ± 741	41 ± 13	35 ± 3
Peak Total Bilirubin (mg/dL)	6.1 ± 1.4	13.1 ± 2.9	N.D.	N.D.
Peak Creatinine (mg/dL)	2.4 ± 0.5	2.8 ± 0.4	N.D.	N.D.
Peak INR *	4.4 ± 1.0 (n = 9)	9.1 ± 0.7 (n = 3)	N.D.	N.D.
Peak PT (s) **	66.6 ± 46.9 (n = 3)	84.2 ± 10 (n = 6)	N.D.	N.D.

INR, international normalized ratio; PT, prothrombin time; N.D. not determined. Data represent mean ± SE of n = 12 survivors, n = 9 non-survivors, n = 10 NLT (overdose patients with no liver transaminase increase), n = 8 controls (healthy volunteers)

^*Only applicable for KU samples;

^**Only applicable for Phoenix samples